Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Weatherald

Showing results (131-140 of 154) with videos related to

Pageof 16
Sort By:
BMJ Open Respiratory Research|March 22, 2024
Inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease with less severe haemodynamics: a post hoc analysis of the INCREASE studyJason Weatherald, Steven D Nathan, Karim El-Kersh, et al.
Plos One|May 16, 2018
Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosisDavid Launay, David Montani, Paul M Hassoun, et al.
The European Respiratory Journal|September 14, 2018
Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertensionJason Weatherald, Athénaïs Boucly, David Launay, et al.
The European Respiratory Journal|November 5, 2021
External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registryAthénaïs Boucly, Jason Weatherald, Laurent Savale, et al.
BMC Health Services Research|December 13, 2023
"None of us are lying": an interpretive description of the search for legitimacy and the journey to access quality health services by individuals living with Long COVIDKatelyn Brehon, Maxi Miciak, Pam Hung, et al.
JACC. Heart Failure|May 22, 2026
Refining the Definition for "Low Risk" in Pulmonary Arterial Hypertension: Time to Reduce Morbidity and MortalityCharles Fauvel, Priscilla Correa Jaque, Yongqi Liu, et al.
Clinical Rheumatology|September 13, 2023
Esophageal motility in systemic sclerosis before and after autologous hematopoietic cell transplantationMatthew M K Woo, Daniel Levin, Dorothy Y Li, et al.
The European Respiratory Journal|October 21, 2017
Management and long-term outcomes of sarcoidosis-associated pulmonary hypertensionAthénaïs Boucly, Vincent Cottin, Hilario Nunes, et al.
Chest|July 22, 2020
Triaging Access to Critical Care Resources in Patients With Chronic Respiratory Diseases in the Event of a Major COVID-19 Surge: Key Highlights From the Canadian Thoracic Society (CTS) Position StatementSamir Gupta, Jane Batt, Jean Bourbeau, et al.
The European Respiratory Journal|October 22, 2021
Mortality trends in pulmonary arterial hypertension in Canada: a temporal analysis of survival per ESC/ERS guideline eraJason G E Zelt, Jordan Sugarman, Jason Weatherald, et al.
Pageof 16

Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
BMJ Open Respiratory Research|March 22, 2024
Inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease with less severe haemodynamics: a post hoc analysis of the INCREASE studyJason Weatherald, Steven D Nathan, Karim El-Kersh, et al.
Plos One|May 16, 2018
Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosisDavid Launay, David Montani, Paul M Hassoun, et al.
The European Respiratory Journal|September 14, 2018
Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertensionJason Weatherald, Athénaïs Boucly, David Launay, et al.
The European Respiratory Journal|November 5, 2021
External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registryAthénaïs Boucly, Jason Weatherald, Laurent Savale, et al.
BMC Health Services Research|December 13, 2023
"None of us are lying": an interpretive description of the search for legitimacy and the journey to access quality health services by individuals living with Long COVIDKatelyn Brehon, Maxi Miciak, Pam Hung, et al.
JACC. Heart Failure|May 22, 2026
Refining the Definition for "Low Risk" in Pulmonary Arterial Hypertension: Time to Reduce Morbidity and MortalityCharles Fauvel, Priscilla Correa Jaque, Yongqi Liu, et al.
Clinical Rheumatology|September 13, 2023
Esophageal motility in systemic sclerosis before and after autologous hematopoietic cell transplantationMatthew M K Woo, Daniel Levin, Dorothy Y Li, et al.
The European Respiratory Journal|October 21, 2017
Management and long-term outcomes of sarcoidosis-associated pulmonary hypertensionAthénaïs Boucly, Vincent Cottin, Hilario Nunes, et al.
Chest|July 22, 2020
Triaging Access to Critical Care Resources in Patients With Chronic Respiratory Diseases in the Event of a Major COVID-19 Surge: Key Highlights From the Canadian Thoracic Society (CTS) Position StatementSamir Gupta, Jane Batt, Jean Bourbeau, et al.
The European Respiratory Journal|October 22, 2021
Mortality trends in pulmonary arterial hypertension in Canada: a temporal analysis of survival per ESC/ERS guideline eraJason G E Zelt, Jordan Sugarman, Jason Weatherald, et al.
Pageof 16